- Home
- NOTV vs MTNB Comparison
NOTV vs MTNB Comparison
Compare NOTV & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- MTNB
- Stock Information
- Founded
- NOTV 1974
- MTNB 2013
- Country
- NOTV United States
- MTNB United States
- Employees
- NOTV N/A
- MTNB N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NOTV Health Care
- MTNB Health Care
- Exchange
- NOTV Nasdaq
- MTNB Nasdaq
- Market Cap
- NOTV 126.3M
- MTNB 3.2M
- IPO Year
- NOTV 1997
- MTNB N/A
- Fundamental
- Price
- NOTV $4.22
- MTNB $0.70
- Analyst Decision
- NOTV Strong Buy
- MTNB Hold
- Analyst Count
- NOTV 3
- MTNB 1
- Target Price
- NOTV $5.92
- MTNB N/A
- AVG Volume (30 Days)
- NOTV 1.5M
- MTNB 890.5K
- Earning Date
- NOTV 02-05-2025
- MTNB 11-13-2024
- Dividend Yield
- NOTV N/A
- MTNB N/A
- EPS Growth
- NOTV N/A
- MTNB N/A
- EPS
- NOTV N/A
- MTNB N/A
- Revenue
- NOTV $490,739,000.00
- MTNB N/A
- Revenue This Year
- NOTV $7.14
- MTNB N/A
- Revenue Next Year
- NOTV $5.73
- MTNB N/A
- P/E Ratio
- NOTV N/A
- MTNB N/A
- Revenue Growth
- NOTV N/A
- MTNB N/A
- 52 Week Low
- NOTV $1.23
- MTNB $0.48
- 52 Week High
- NOTV $11.42
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- NOTV 48.58
- MTNB 50.58
- Support Level
- NOTV $4.17
- MTNB $0.55
- Resistance Level
- NOTV $5.67
- MTNB $1.43
- Average True Range (ATR)
- NOTV 0.55
- MTNB 0.15
- MACD
- NOTV -0.11
- MTNB 0.04
- Stochastic Oscillator
- NOTV 22.87
- MTNB 23.32
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.